Shalina Sheryl Ousman

Title: Shalina Sheryl Ousman: Innovator in Therapeutic Applications of Alpha B-Crystallin

Introduction

Shalina Sheryl Ousman is a prominent inventor based in Stanford, CA (US). She has made significant contributions to the field of therapeutic applications, particularly in the treatment of inflammatory diseases. With a total of 3 patents to her name, her work focuses on innovative methods to address complex health issues.

Latest Patents

Ousman's latest patents include groundbreaking inventions that utilize alpha B-crystallin as a therapeutic agent. One of her notable patents is titled "Alpha B-crystallin as a therapy for multiple sclerosis." This invention provides methods for treating inflammatory diseases by administering an effective amount of an agent that offers alpha B-crystallin activity. The dosage is designed to suppress or prevent the initiation, progression, or relapses of diseases, including the progression of established conditions. In certain embodiments, the methods involve administering alpha B-crystallin protein to individuals with pre-existing inflammatory disease conditions to prevent relapses.

Another significant patent is "Alpha B-crystallin as a therapy for ischemia or inflammation." Similar to her previous work, this invention outlines methods for treating inflammatory diseases through the administration of alpha B-crystallin. The focus remains on providing effective doses to suppress or prevent disease progression and relapses, showcasing her commitment to advancing therapeutic strategies.

Career Highlights

Throughout her career, Ousman has worked with esteemed institutions, including Leland Stanford Junior University and the United States Government as represented by the Department of Veterans Affairs. Her research has garnered attention for its potential impact on treating debilitating conditions.

Collaborations

Ousman has collaborated with notable figures in her field, including Lawrence Steinman and William H. Robinson. These partnerships have contributed to the advancement of her research and the development of her innovative patents.

Conclusion

Shalina Sheryl Ousman stands out as a leading inventor in the therapeutic application of alpha B-crystallin. Her contributions to the treatment of inflammatory diseases reflect her dedication to improving health outcomes through innovative research.